posted on 2020-04-30, 17:37authored byPatanachai
K. Limpikirati, Bo Zhao, Xiao Pan, Stephen J. Eyles, Richard W. Vachet
Diethylpyrocarbonate
(DEPC)-based covalent labeling together with
mass spectrometry is a promising tool for the higher-order structural
analysis of antibody therapeutics. Reliable information about antibody
higher-order structure can be obtained, though, only when the protein’s
structural integrity is preserved during labeling. In this work, we
have evaluated the applicability of DEPC reaction kinetics for ensuring
the structural integrity of monoclonal antibodies (mAbs) during labeling.
By monitoring the modification extent of selected proteolytic fragments
as a function of DEPC concentration, we find that a common DEPC concentration
can be used for different monoclonal antibodies in formulated samples
without perturbing their higher-order structure. Under these labeling
conditions, we find that the antibodies can accommodate up to four
DEPC modifications without being structurally perturbed, indicating
that multidomain proteins can withstand more than one label, which
contrasts to previously studied single-domain proteins. This more
extensive labeling provides a more sensitive measure of structure,
making DEPC-based covalent labeling-mass spectrometry suitable for
the higher-order structural analyses of mAbs.